• Medicine
  • 17 June
  • FDA to approve GSK & Spero Therapeutics' Tebipenem HBr
    2
  • 18 June
  • FDA to approve Arcalyst technology transfer
    2
  • FDA to approve Merck's Welireg + Keytruda or Keytruda Qlex
    2
  • 28 June
  • FDA to approve Unicycive's Oxylanthanum carbonate
    2
  • 29 June
  • FDA to approve Viridian Therapeutics' Veligrotug
    2
  • 30 December
  • CDC to issue Level 4 warning by December 31
    2
  • FDA approves Retatrutide this year?
    2

mp